Altair has announced the acquisition of Univa, a company the specialises in workload management, scheduling, and optimisation solutions for HPC and artificial intelligence (AI) on-premises and in the cloud
Insilico Medicine, a company that specialises in the development of artificial intelligence for drug discovery and development, announced the launch of a new system for COVID-19 basic and clinical research
Oxbotica, a company that specialises in autonomous vehicle software, has announced that it has been granted automated vehicle (AV) permit recommendation by TÜV SÜD to conduct live trials in Germany
During the International Conference on High-Energy Physics (ICHEP 2020), the ATLAS collaboration presented results which demonstrate a new way of using the LHC, namely as a high-energy photon collider directly probing electroweak interactions
Tohoku University Graduate School of Engineering, Graduate School of Information Sciences, and NEC Corporation have announced a collaboration aimed at developing composite materials for aircraft
The Centre for Connected & Autonomous Automotive Research (CCAAR) has asserted that fresh thinking from new industry entrants and innovative academics will play a key role in realising future mobility
Airflow simulation software from Dassault Systèmes was recently used for a collaborative project to reduce the risk of virus propagation inside the St Francis Hospital in Marange-Silvange in northeastern France
CERN has announced that its CLOUD collaboration has revealed a new mechanism that drives winter smog episodes in cities
Intel has announced plans to provide $50 Million to accelerate access to technology and enable new scientific discovery to combat the current COVID-19 pandemic and future crisis.
Researchers at the US Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL) identified 77 small-molecule drug compounds that warrant further study in the fight against the SARS-CoV-2 virus
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
